Viela Bio, Inc. (36) | Uncategorized (9)

Recent Contracts

Form of Tender and Support Agreement (Filed With SEC on February 1, 2021)
Description of Securities (Filed With SEC on March 25, 2020)
Offer Letter, by and between the Registrant and Mitchell Chan, dated August 15, 2018 (Filed With SEC on August 29, 2019)
Offer Letter, by and between the Registrant and William Ragatz, dated November 27, 2018 (Filed With SEC on August 29, 2019)
BioWa Sublicense Agreement, by and between the Registrant and MedImmune, LLC, dated as of February 23, 2018 (Filed With SEC on August 29, 2019)
Supplemental Agreement dated as of August 14, 2018, by and between SBI Biotech Co. Ltd. and the Registrant (Filed With SEC on August 29, 2019)
BioWa/Lonza Sublicense Agreement, by and between the Registrant and MedImmune, LLC, dated as of February 23, 2018 (Filed With SEC on August 29, 2019)
Lonza Sublicense Agreement, by and between the Registrant and MedImmune, LLC, dated as of February 23, 2018 (Filed With SEC on August 29, 2019)
Medical Research Council Payment Agreement, by and between the Registrant and MedImmune Limited, dated February 23, 2018 (Filed With SEC on August 29, 2019)